Friday, 14 December 2018

Key personnel THERAKIND

Susan Conroy (Company CEO) is an experienced pharmaceutical manager, specialising in the identification, evaluation, management and commercialisation of pharmaceutical and biotechnology projects.

Louise Rawcliffe (BSc, MBA) has experience in managing clinical trial programmes and global compliance programmes for clinical trials.

Jackie Winslade is experienced in defining worldwide regulatory strategy, product development planning, coordinating and directing the preparation and review of worldwide regulatory submissions and establishing effective working relationships both within and outside the company.

Julie-Ann Penton has expertise in writing and compiling CMC components of regulatory applications and has also acted as pharmaceutical expert for a number of EU submissions.

Helen Buck has been involved in various aspects of clinical development and clinical trials for over 15 years.

Copyright © NeoVanc | All rights reserved. Read the disclaimer.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no: 602041
Call: FP7-HEALTH-2013-INNOVATION-1
Privacy policy | Terms and conditions

E-mail: info@penta-id.org